Vertex Pharma forecasts 2026 revenue in-line, expects growth in cystic fibrosis treatmentsReuters • 02/12/26
Why Vertex Pharmaceuticals (VRTX) is a Top Momentum Stock for the Long-TermZacks Investment Research • 02/12/26
Seeking Clues to Vertex (VRTX) Q4 Earnings? A Peek Into Wall Street Projections for Key MetricsZacks Investment Research • 02/09/26
WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell EngagerPRNewsWire • 02/03/26
Wall Street Analysts Think Vertex (VRTX) Is a Good Investment: Is It?Zacks Investment Research • 01/23/26
Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12thBusiness Wire • 01/20/26
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030The Motley Fool • 01/14/26
Vertex Pharmaceuticals Incorporated (VRTX) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/13/26
Will Vertex (VRTX) Beat Estimates Again in Its Next Earnings Report?Zacks Investment Research • 01/12/26
Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor MeetingsBusiness Wire • 01/11/26
Vertex Pharmaceuticals (VRTX) Stock Dips While Market Gains: Key FactsZacks Investment Research • 01/09/26